Tyr-DD for COVID-19
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets.
Scientists have proposed 10,000+ potential treatments.
c19early.org analyzes
200+ treatments.
We have not reviewed Tyr-DD in detail.
, Inhibition of SARS-CoV-2 3CLpro by chemically modified tyrosinase from Agaricus bisporus, RSC Medicinal Chemistry, doi:10.1039/D4MD00289J
A novel antiviral and non-cytotoxic bioconjugate of tyrosinase from Agaricus bisporus (AbTyr)-dextran-aspartic acid (6 kDa) polymer is developed.
